Concentra Group Holdings Parent (NYSE:CON) versus Pheton (NASDAQ:PTHL) Head to Head Review

Pheton (NASDAQ:PTHL) and Concentra Group Holdings Parent (NYSE:CON) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation and institutional ownership.

Risk and Volatility

Pheton has a beta of 5.4, meaning that its share price is 440% more volatile than the S&P 500. Comparatively, Concentra Group Holdings Parent has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500.

Profitability

This table compares Pheton and Concentra Group Holdings Parent’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Pheton	N/A	N/A	N/A
Concentra Group Holdings Parent	7.97%	47.14%	6.48%

Earnings and Valuation

This table compares Pheton and Concentra Group Holdings Parent”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pheton	$305,215.00	6.75	-$660,000.00	N/A	N/A
Concentra Group Holdings Parent	$2.23 billion	1.64	$166.41 million	$1.39	20.53

Concentra Group Holdings Parent has higher revenue and earnings than Pheton.

Analyst Ratings

This is a summary of current recommendations for Pheton and Concentra Group Holdings Parent, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pheton	1	0	0	0	1.00
Concentra Group Holdings Parent	0	1	6	0	2.86

Concentra Group Holdings Parent has a consensus target price of $30.20, suggesting a potential upside of 5.81%. Given Concentra Group Holdings Parent’s stronger consensus rating and higher possible upside, analysts plainly believe Concentra Group Holdings Parent is more favorable than Pheton.

Summary

Concentra Group Holdings Parent beats Pheton on 8 of the 10 factors compared between the two stocks.

About Pheton

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.

About Concentra Group Holdings Parent

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers’ compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.